Philadelphia-negative acute lymphoblastic leukemia developing in a CML patient in imatinib mesylate-induced complete cytogenetic remission.

Cherrier-De Wilde, S; Rack, K; Vannuffel, P; Delannoy, A; Hagemeijer, A

Cherrier-De Wilde, S; Rack, K; Vannuffel, P; Delannoy, A; Hagemeijer, A.

Leukemia ; 17(10): 2046-8, 2003 Oct.

Article in En | MEDLINE | ID: mdl-14513056

Subject(s)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy; Philadelphia Chromosome; Piperazines/therapeutic use; Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics; Pyrimidines/therapeutic use; Adult; Antineoplastic Agents/therapeutic use; Benzamides; Humans; Imatinib Mesylate; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics; Male

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Philadelphia Chromosome / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Adult / Humans / Male Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2003 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links